A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients.
Raizer JJ, Giglio P, Hu J, Groves M, Merrell R, Conrad C, Phuphanich S, Puduvalli VK, Loghin M, Paleologos N, Yuan Y, Liu D, Rademaker A, Yung WK, Vaillant B, Rudnick J, Chamberlain M, Vick N, Grimm S, Tremont-Lukats IW, De Groot J, Aldape K, Gilbert MR; Brain Tumor Trials Collaborative.
Raizer JJ, et al. Among authors: yuan y.
J Neurooncol. 2016 Jan;126(1):185-192. doi: 10.1007/s11060-015-1958-z.
J Neurooncol. 2016.
PMID: 26476729
Free PMC article.
Clinical Trial.